Skip to main content
. 2021 Sep 30;45(5):629–640. doi: 10.4093/dmj.2021.0163

Table 1.

Currently available insulins and their action time

Type of insulin Onset time Peak time Duration of action
Ultrarapid-acting
Insulin aspart (Fiasp®) 4 min 1–3 hr 3–5 hr
Insulin lispro-aabc (Lyumjev®) 2 min 1–2 hr ~4.6 hr
Rapid-acting
Insulin lispro (Humalog®) 10–15 min 1–2 hr 3–5 hr
Insulin aspart (NovoRapid®) 10–15 min 1–3 hr 3–5 hr
Insulin glulisine (Apidra®) 10–15min 1–2 hr 2–4 hr
Short-acting
Regular insulin (Humulin R®) 30 min 2–3 hr 6.5 hr
Intermediate-acting
NPH insulin (Humulin N®) 1–3 hr 5–8 hr ~18 hr
Long-acting
Insulin glargine (Lantus®) 1.5 hr No peak ~24 hr
Insulin glargine U300 (Toujeo®) ~6 hr No peak 24–36 hr
Insulin detemir (Levemir®) 3–4 hr 6–8 hr ~24 hr
Insulin degludec (Tresiba®) 30–90 min No peak ~42 hr
Premixed
70% NPH+30% regular insulin (Humulin® 70/30)
25% lispro+75% neutral protamine lispro (Humalog® Mix25)
50% lispro+50% neutral protamine lispro (Humalog® Mix50)
30% aspart+70% neutral protamine aspart (Novomix® 30)
50% aspart+50% neutral protamine aspart (Novomix® 50)
70% degludec+30% aspart (Ryzodeg®)

NPH, Neutral Protamine Hagedorn.